GPX4 and cancer: Previous studies have proved that the treatment of several cancer types including pancreatic, lung, colorectal, and ovarian cancers, the ferroptosis inducers such as RSL3 and RSL3A augment synergistically the anticancer effects of the drug cisplatin by blocking system Xc− or Gpx4 in the body [72].